aripiprazole has been researched along with Disease Exacerbation in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Falkai, P; Schmitt, A | 1 |
| Bose, A; Citrome, L; Claxton, A; Du, Y; Ehrich, EW; Risinger, R; Silverman, BL; Stankovic, S; Zummo, J | 1 |
| Fujishiro, H; Iwamoto, K; Ozaki, N | 1 |
| Sikich, L | 1 |
| Schwankhaus, J; Singh, S | 1 |
| Ahuja, N; Lloyd, AJ | 1 |
1 review(s) available for aripiprazole and Disease Exacerbation
| Article | Year |
|---|---|
Efficacy of atypical antipsychotics in early-onset schizophrenia and other psychotic disorders.
Topics: Adolescent; Adult; Age of Onset; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Brain Diseases; Child; Chronic Disease; Clozapine; Comorbidity; Disease Progression; Humans; Magnetic Resonance Imaging; Olanzapine; Piperazines; Prognosis; Psychotic Disorders; Quinolones; Schizophrenia; Thiazoles; Treatment Failure | 2008 |
1 trial(s) available for aripiprazole and Disease Exacerbation
| Article | Year |
|---|---|
Effect of aripiprazole lauroxil on agitation and hostility in patients with schizophrenia.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Aripiprazole; Asia; Disease Progression; Europe; Female; Hostility; Humans; Injections, Intramuscular; Male; Middle Aged; Psychiatric Status Rating Scales; Psychomotor Agitation; Recurrence; Schizophrenia; Schizophrenic Psychology; Time Factors; Treatment Outcome; United States; Young Adult | 2016 |
4 other study(ies) available for aripiprazole and Disease Exacerbation
| Article | Year |
|---|---|
Innovative potential treatment strategies for schizophrenia and biomarkers for Alzheimer's disease.
Topics: Alzheimer Disease; Antipsychotic Agents; Aripiprazole; Biomarkers; Disease Progression; Histone Deacetylase Inhibitors; Humans; Piperazines; Quinolones; Schizophrenia | 2013 |
Effect of aripiprazole augmentation for depressive symptoms changes with progression of Lewy body disease.
Topics: Antiparkinson Agents; Antipsychotic Agents; Aripiprazole; Depressive Disorder, Major; Disease Progression; Drug Synergism; Female; Humans; Lewy Body Disease | 2017 |
Olfactory disturbance in Parkinson disease.
Topics: Aged; Anticonvulsants; Antiparkinson Agents; Antipsychotic Agents; Aripiprazole; Biomarkers; Brain; Cognition Disorders; Constipation; Diagnosis, Differential; Disease Progression; Electroencephalography; Hallucinations; Humans; Levetiracetam; Lewy Body Disease; Male; Olfactory Pathways; Parkinson Disease; Piperazines; Piracetam; Quinolones; REM Sleep Behavior Disorder; Treatment Failure; Tremor | 2009 |
Aripiprazole and worsening of psychosis: a case report.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Disease Progression; Female; Humans; Piperazines; Psychotic Disorders; Quinolones; Recurrence | 2007 |